Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Isracann Biosciences Inc (ISCNF)

Isracann Biosciences Inc (ISCNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ISCNF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 unch
on 04/19/24
0.0050 -98.00%
on 04/02/24
unch (unch)
since 03/19/24
3-Month
0.0001 unch
on 04/19/24
0.0052 -98.08%
on 01/26/24
-0.0059 (-98.33%)
since 01/16/24
52-Week
0.0001 unch
on 04/19/24
0.0368 -99.73%
on 06/16/23
-0.0199 (-99.50%)
since 04/19/23

Most Recent Stories

More News
Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement

VANCOUVER, British Columbia, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (unch)
Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada

VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (unch)
Isracann Biosciences Renews Leadership to Meet Changing Demands

VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (unch)
Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers

VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (unch)
Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (unch)
UPDATE - Isracann Signs LOI to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (unch)
Isracann Signs LOI to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (unch)
Isracann Advises on Recent Activities and 2022 Outlook

VANCOUVER, British Columbia, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (unch)
Isracann Appoints Operational Expert Phil Floucault as CEO and Grants Options

VANCOUVER, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (unch)
Isracann Appoints Experienced Farm Manager and Updates Israeli Cannabis Operations

VANCOUVER, British Columbia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.   (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0001
2nd Resistance Point 0.0001
1st Resistance Point 0.0001
Last Price 0.0001
1st Support Level 0.0001
2nd Support Level 0.0001
3rd Support Level 0.0001

See More

52-Week High 0.0368
Fibonacci 61.8% 0.0228
Fibonacci 50% 0.0185
Fibonacci 38.2% 0.0141
Last Price 0.0001
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar